Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 51, Pages 21170-21179Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.R117.807560
Keywords
-
Categories
Funding
- Fonds National de la Recherche Scientifique Fellowship FRIA Grant [1.E091.14]
- Fonds National de la Recherche Scientifique Fellowship TELEVIE Grant [7455115F]
Ask authors/readers for more resources
The proteasome is the major protease responsible for the production of antigenic peptides recognized by CD8(+) cytolytic T cells (CTL). These peptides, generally 8-10 amino acids long, are presented at the cell surface by major histocompatibility complex (MHC) class I molecules. Originally, these peptides were believed to be solely derived from linear fragments of proteins, but this concept was challenged several years ago by the isolation of anti-tumor CTL that recognized spliced peptides, i.e. peptides composed of fragments distant in the parental protein. The splicing process was shown to occur in the proteasome through a transpeptidation reaction involving an acyl-enzyme intermediate. Here, we review the steps that led to the discovery of spliced peptides as well as the recent advances that uncover the unexpected importance of spliced peptides in the composition of the MHC class I repertoire.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available